Constitutive Cytomorphologic Features of Medullary Thyroid Carcinoma Using Different Staining Methods.
cytology
fine-needle aspiration
medullary thyroid carcinoma
sensitivity
specificity
thyroid
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
02 Aug 2021
02 Aug 2021
Historique:
received:
07
07
2021
revised:
28
07
2021
accepted:
29
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
(1) Background: Accurate preoperative identification of medullary thyroid carcinoma (MTC) is challenging due to a spectrum of cytomorphologic features. However, there is a scarcity of studies describing the cytomorphologic features as seen on fine-needle aspiration (FNA) smears prepared using different staining methods. (2) Methods: We performed a retrospective study on MTC cases with available FNA slides from 13 hospitals distributed across 8 Asia-Pacific countries. The differences in the constitutive cytomorphologic features of MTC with each cytopreparatory method were recorded. A comparative analysis of cytologic characteristics was carried out with appropriate statistical tests. (3) Results: Of a total of 167 MTC samples retrospectively recruited, 148 (88.6%) were interpreted as MTC/suspicious for MTC (S-MTC). The staining methods used were Papanicolaou, hematoxylin-eosin, and Romanowsky stains. Seven out of the eleven cytologic criteria can be readily recognized by all three cytopreparatory methods: high cellularity, cellular pleomorphism, plasmacytoid cells, round cells, dyshesive cells, salt-and-pepper chromatin, and binucleation or multinucleation. An accurate diagnosis was achieved in 125 (84.5%) of the 148 samples whose FNAs exhibited five or more atypical features. Conclusions: The present work is the first study on MTC to compare the morphological differences among the cytologic staining techniques. We investigated the constitutive features and the reliability of diagnostic parameters. A feasible scoring system based upon cytomorphologic data alone is proposed to achieve a high degree of diagnostic accuracy.
Identifiants
pubmed: 34441330
pii: diagnostics11081396
doi: 10.3390/diagnostics11081396
pmc: PMC8392035
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Research Foundation of Korea
ID : NRF-2020R1F1A1070028
Références
Cytopathology. 2017 Dec;28(6):455-466
pubmed: 29094782
Diagn Cytopathol. 2000 Jun;22(6):351-8
pubmed: 10820528
Cancer Cytopathol. 2018 Jun;126(6):397-405
pubmed: 29579362
J Pathol Transl Med. 2017 Nov;51(6):571-578
pubmed: 29073758
Acta Pathol Jpn. 1979 Jul;29(4):653-9
pubmed: 463561
Arch Pathol Lab Med. 1978 Sep;102(9):445-7
pubmed: 210736
Endocr Pract. 2013 Nov-Dec;19(6):920-7
pubmed: 23757627
Cancer Cytopathol. 2019 Mar;127(3):181-191
pubmed: 30668897
Rom J Morphol Embryol. 2019;60(2):369-381
pubmed: 31658309
Endocrinol Metab (Seoul). 2020 Dec;35(4):811-819
pubmed: 33212545
Lancet Diabetes Endocrinol. 2021 Apr;9(4):225-234
pubmed: 33662333
Am J Clin Pathol. 2021 Apr 26;155(5):680-689
pubmed: 33269383
Cancer. 1998 Oct 25;84(5):295-302
pubmed: 9801204
Endocr J. 2017 Nov 29;64(11):1099-1104
pubmed: 28883261
Acta Pathol Jpn. 1989 Jun;39(6):393-9
pubmed: 2481937
Curr Oncol. 2019 Oct;26(5):338-344
pubmed: 31708652
Thyroid Res. 2018 Oct 30;11:15
pubmed: 30450128
Histopathology. 1988 Dec;13(6):645-56
pubmed: 2466753
J Surg Oncol. 2005 Jul 1;91(1):56-60
pubmed: 15999359
Arch Pathol Lab Med. 2019 Oct;143(10):1171
pubmed: 31556708
J Pathol Transl Med. 2017 Nov;51(6):517-520
pubmed: 29046516
Diagn Cytopathol. 2019 Sep;47(9):943-947
pubmed: 31190466
Diagn Cytopathol. 2021 Jan;49(1):60-69
pubmed: 32827355
Diagn Cytopathol. 2017 Dec;45(12):1148-1152
pubmed: 28802094
Oncol Lett. 2016 Jun;11(6):3870-3874
pubmed: 27313709
Arch Pathol Lab Med. 2008 Aug;132(8):1241-50
pubmed: 18684023
Pathol Res Pract. 1984 May;178(5):461-6
pubmed: 6087305
Head Neck. 2014 Aug;36(8):1216-23
pubmed: 23955938
Ann Intern Med. 2013 Sep 3;159(5):325-32
pubmed: 24026318
Gland Surg. 2020 Oct;9(5):1878-1900
pubmed: 33224863
Diagn Cytopathol. 2016 Jan;44(1):45-51
pubmed: 26481456
BMC Cancer. 2018 Mar 15;18(1):291
pubmed: 29544469
J Am Soc Cytopathol. 2017 Nov - Dec;6(6):217-222
pubmed: 31043290
Clin Endocrinol (Oxf). 2015 Feb;82(2):280-5
pubmed: 25047365
Cancer Cytopathol. 2020 Apr;128(4):238-249
pubmed: 31883438
Front Endocrinol (Lausanne). 2021 Jun 25;12:701877
pubmed: 34248855
J Surg Oncol. 1994 Dec;57(4):252-9; discussion 259-60
pubmed: 7990481